|
Cannabis Science Expands Clinical Studies to Include Selected Patients for Asthma, Several Important Pain Targets, and Sleep Deprivation With Additional Medications
|
13-09-16 |
|
Cannabis Science Receives Initial Batch of Nebulizers for CBIS MDI Rescue Inhalers Targeting Asthma/COPD; Prepares Packaging & Distribution
|
06-09-16 |
|
Cannabis Science Activates Its Critical Financial Security Department to Specialize in the Worldwide Industry Deficiency in Risk Mitigation, Banking, Payment Processing, and Cash and Asset Movement
|
02-09-16 |
|
Cannabis Science and the Research Foundation Begins Protocols for California Legal Patients to Receive the New CBIS MDI Rescue Inhaler for Its First Observational Study Intending to Lead Into Clinical Trials
|
12-08-16 |
|
Cannabis Science Orders First Batch Inhalation Medication and Adds CBIS MDI Rescue Inhaler for Asthma/COPD via Nebulizer, Targeting 25+ Legal States, and National Market Variables
|
11-08-16 |
|
Twenty Acre Indoor/Outdoor Cultivation Facility in Northern California in the Final Stages of Escrow Awaiting Transfer of Ownership to Cannabis Science, Inc.
|
01-08-16 |
|
Cannabis Science Develops Inhalation Medication for Those Suffering Asthma/COPD via Nebulizer, Targets National Markets
|
29-07-16 |
|
Cannabis Science 2016 Growth Guidance; Project Briefs, Cash-Flow Projections, and Current Historic Cannabis Industry Advancements; Industry Growth Indicators
|
20-07-16 |
|
CFA Announces That the 2016 Ronald H. Brown African Affairs Series Will Be a Bipartisan Forum to Develop Policy Recommendations for the Next U.S. Presidential Administration
|
18-07-16 |
|
CBIS CEO, Mr. Raymond C. Dabney, Invited to Serve as Co-Chair of the Constituency for Africa's 2016 Ronald H. Brown African Affairs Series in September
|
11-07-16 |
